Orphan designation: Obecabtagene autoleucel Treatment of acute lymphoblastic leukaemia, 13/04/2022 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 July 2025 - 14:00

Orphan designation: Obecabtagene autoleucel Treatment of acute lymphoblastic leukaemia, 13/04/2022 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2605

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters